Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Patient safety

Diabetics told to check faulty ‘hypo’ kits

The UK medicines safety regulator has asked patients with diabetes to check whether they have certain batches of GlucaGen HypoKits after a fault was identified with the kits’ needles.

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a patient level recall of the affected kits, which are used for the emergency treatment of severe hypoglycaemia. The fault means that some needles have detached from the syringe in the kits, rendering them unusable.

Affected batches should not be used, the MHRA says, because a delay in treatment could have severe health consequences in an emergency situation.

Novo Nordisk, the manufacturer of the kits, discovered that 0.006% of needles have detached from the syringe in the GlucaGen HypoKit.

“Whilst only a small number of these kits are affected by this fault, it is important that people are confident their treatment will be effective in the event of emergency,” says Gerald Heddell, the MHRA’s director of inspection, enforcement and standards. “People with these kits should check which batch their kit is from and, where necessary, get a replacement from a pharmacist.”.

The affected batches are FS6W939, FS6X059, FS6X196, FS6X590, FS6X717, FS6X899 and FS6Y024, which have expiry dates ranging from 31 May 2018 to 30 September 2018 and were first distributed between 26 February 2016 and 6 May 2016.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2016.20201669

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.


Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • GlucaGen HypoKit

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.